Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies
pharmaphorum
DECEMBER 13, 2022
Both the EMA and FDA have released draft guidance on the issue and are currently soliciting feedback. Increased study adherence: Patients are most familiar with their own devices, and the ability to download an application and complete entries on a device they understand increases their adherence to the study requirements.
59 
Let's personalize your content